Coromandel International uploaded its investor presentation for the first quarter of FY27 (Q1FY27) on July 24, 2026. The filing supports the conference call scheduled to discuss the financial results for the quarter ended June 30, 2026, ensuring stakeholders have access to the relevant data prior to the discussion.

The company disclosed the availability of the presentation in a letter dated July 24, 2026, addressed to the National Stock Exchange of India Limited and BSE Limited. This disclosure was made pursuant to Regulation 46(2)(o) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates that investor presentations made during conference calls be uploaded to the company's website.

Filing Details

The submission confirms that the materials presented during the conference call are now publicly accessible. The key details of the filing are outlined below:

B. Shanmugasundaram, Company Secretary & Compliance Officer, signed the communication. The letter references a prior notice dated July 21, 2026 (Ref No: 2026-27/025), which had announced the conference call. The current filing (Ref No: 2026-27/029) serves to confirm compliance with the post-call disclosure requirement.

Coromandel International Limited reported a consolidated net profit of ₹381.56 crore for the quarter ended June 30, 2026 (Q1FY27), a 24% decline from ₹501.59 crore in the same period last year. Standalone net profit fell more sharply by 26% to ₹377 crore, down from ₹508 crore in Q1FY26. Despite the profit contraction, revenue from operations grew by 15% to ₹8,164.77 crore on a consolidated basis and 10% to ₹7,792 crore standalone, reflecting volume growth that was offset by rising input costs.

The profitability pressure stemmed primarily from elevated raw material costs triggered by the ongoing Middle East crisis, which weighed heavily on the Fertiliser business. Subsidy rates remained inadequate to fully offset these increased input costs. Consequently, consolidated EBITDA declined 3% to ₹761 crore from ₹782 crore, while standalone EBITDA dropped 15% to ₹626 crore from ₹738 crore. The Board of Directors approved the unaudited financial results at its meeting held on July 23, 2026.

Segment Performance and Operational Updates

While the subsidy-dependent fertiliser segment faced headwinds, non-subsidy businesses delivered robust growth. The Crop Protection segment recorded a strong performance, with segment revenue growing 20% year-on-year to ₹870 crore. This growth was driven by exports and B2B sales, supported by an improved product mix. EBITDA for this segment increased 44% to ₹159 crore. The Retail Business also continued its growth trajectory, aided by network expansion and deeper farmer engagement across fertilisers, specialty nutrients, and organic products.

Operationally, the company stabilised its newly commissioned Phosphoric Acid and Sulphuric Acid plants at Kakinada, strengthening backward integration. The brownfield fertiliser granulation project, adding 7.5 lakh tons of annual capacity, is progressing as planned for completion in Q4 FY27. Additionally, the capacity expansion for a key molecule at Sarigam is on track for commissioning in Q2 FY27.

Strategic Disclosures and Board Approvals

Alongside the results, the Board approved the conversion of a loan amounting to approximately ₹108 crore into equity shares of Coromandel Chemicals Limited, a wholly owned subsidiary, at an issue price of ₹39.95 per share. The Board also approved restructuring loans worth USD 9.70 Million given to Baobab Mining and Chemicals Corporation S A (BMCC), a step-down subsidiary, into equity or preference shares. These disclosures were made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

What the Numbers Show

The divergence between revenue growth and profit decline highlights the sensitivity of Coromandel’s core fertiliser business to global geopolitical shocks. While the 15% consolidated revenue increase demonstrates strong market demand and share retention, the 24% drop in PAT indicates that margin compression in the high-volume fertiliser segment currently outweighs the operational leverage gained from high-growth, higher-margin segments like Crop Protection. The stabilisation of new acid plants suggests future cost mitigation strategies are in place, but near-term earnings remain vulnerable to raw material volatility.